12 -
13
May
Wednesday
Reinventing GPCR drug discovery using systems biology and Artificial Intelligence
We integrate experimental and computational pharmacology to reveal critical properties of novel GPCR drug candidates.
The InterAx Platform
Compounds
The InterAx Platform
Time-resolved cellular assays
Systems biology analysis
Clustering
Better prediction of in vivo effects
Compounds
Time-resolved cellular assays
Systems biology analysis
Clustering
Better prediction of in vivo effects
InterAx helps partners to accelerate and optimize hit‑to‑lead identification for GPCRs.
With Support From
Previous
Next
Featured News
APR 2020
A Spanish-Swiss Liaison to fight COVID-19
APR 2020
InterAx Biotech supporting the COVID-19 initiative SARS-CoV-2/ACE-2 pseudovirus entry blocking assay
DEC 2019
InterAx Biotech and GPCR Therapeutics Inc collaborate for the identification of compounds with superior biological properties targeting GPCR heteromers
Meeting Opportunities
08 -
10
June
Tuesday
14 -
18
June
Monday
No event found!
